{"id":5849,"date":"2017-02-07T12:06:14","date_gmt":"2017-02-07T12:06:14","guid":{"rendered":"https:\/\/www.wma.net\/wp-content\/uploads\/2016\/11\/WHPA_Joint_Statement_on_Counterfeiting.pdf"},"modified":"2017-02-07T12:06:14","modified_gmt":"2017-02-07T12:06:14","slug":"whpa_joint_statement_on_counterfeiting-2","status":"inherit","type":"attachment","link":"https:\/\/www.wma.net\/es\/que-hacemos\/educacion\/medicamentos-falsos\/whpa_joint_statement_on_counterfeiting-2\/","title":{"rendered":"WHPA_Joint_Statement_on_Counterfeiting"},"author":2,"comment_status":"open","ping_status":"closed","template":"","meta":[],"acf":[],"description":{"rendered":"

WHPA_Joint_Statement_on_Counterfeiting<\/a><\/p>\n

…
\nWHPAjointstatementoncounterfeitingofmedicalproducts
\nBackground
\nAll health care professionals have a common goal to protect the well-being of patients in
\nall parts of the world from poor quality, substandard and counterfeit medical products.
\nPro-active steps must be taken in collaboration with Governments and other key
\nstakeholders of the legitimate supply chain such as the pharmaceutical manufacturers
\nand distributors to ensure the quality, safety and efficacy of all medical products
\navailable in countries, in accordance with recognised international standards. This
\nform of quality assurance applies to both branded and generic products, to both the
\nprivate and public sectors, and to both imported and locally manufactured products.
\nThe World Health Professions Alliance WHPA represents more than 26 million health care professionals in
\nmore than 130 countries and is an alliance of the International Council of Nurses (ICN), the International
\nPharmaceutical Federation (FIP), the World Confederation for Physical Therapy (WCPT), the World Dental
\nFederation (FDI) and the World Medical Association (WMA). WHPA is extremely concerned about
\nthe infiltration and sale of counterfeit medical products of the legitimate supply chain in causing life
\nthreatening adverse effects in patients.
\nCounterfeit medical products must be considered to be unsafe and ineffective. They result in wasted
\nresources spent on purchasing, inventory, transport and dispensing with little or no effect or even cause
\nharm to the patient. Counterfeit medicinal products threaten patient safety by, at best, causing no
\nimprovement or, worse, causing added burden of disease and even death; endanger public health
\nby increasing the risk of antimicrobial resistance; and patients\u2019 trust in health professionals and health
\nsystems, who are seen not to be able to provide an adequate treatment. Public health and patient safety
\nare being put at risk and now is the time to act.
\nHealth professions are crucial to combating counterfeit medical products. By visual inspections, nurses,
\npharmacists, physicians, dentists and physical therapists who are constantly in contact with medicines and
\nmedical devices may be able to detect anomalies in the physical appearances of medical products and
\ntrigger investigation. Health professionals need to increasingly consider counterfeit medicines as a reason
\nfor non-response or unexpected response in pharmacotherapy in the patients they care for. Yet, for health
\nprofessionals to be able to effectively play their role, it is necessary that national authorities set up effective
\nsystems for the collection of information indicating possible counterfeits signal, verify and investigate this
\ninformation and feed back the results to those who have provided the information.
\nThis global and deadly phenomenon of counterfeit medical products will only be eradicated through
\nan agreed framework of effective coordination, cooperation and action at the global level. The WHPA
\nagrees to step up its commitment and promote the awareness of the dangers posed by counterfeit medical
\nproducts among health professionals, consumers and patients and their national governments.
\nDesign:\u2013Print:
\nwww.whpa.org\/counterfeit_campaign.htm
\nBEAWARE
\nCounterfeit Medecine
\nCounterfeit Medecine
\nCounterfeit
\nCounterfeit Medecine
\nCounterfeit Medecine
\nCounter feit
\nM e d e c i n e
\nC oC o u n t e r f e i t M e d e c i n e
\nBEAWARE
\nBEAWARE
\nM
\nE
\nD
\nIC
\nIN
\nE
\nS
\nC
\nO
\nU
\nN
\nT
\nE
\nR
\nF
\nE
\nIT
\nThe Seven key principles
\nAgainst this background, the WHPA identifies the following 7 key principles for
\nenabling international cooperation and exchange of information among relevant
\nstakeholders involved in detecting and combating counterfeit medical products:
\n1. \u0007The primary focus of combating counterfeit medical products is the protection of public health and
\nrecognition that the main victims of counterfeiting are patients.
\n2. \u0007Counterfeiting of medical products, including the entire range of activities from manufacturing to
\nknowingly providing them to patients, is a vile and serious criminal offense that puts human lives at risk
\nand undermines the credibility of health systems.
\n3. \u0007A comprehensive strategy to combat counterfeiting of medical products require an active participation
\nthat involves all stakeholders of the public sector and the civil society through organizations representing
\nhealth professionals, patients, manufacturers, distributors, and as well as the media and governments.
\n4. \u0007Education of health professionals is crucial for detection and prevention of counterfeit medical products
\nand is required in order for them to educate patients and populations about the risks of buying
\ncounterfeit medical products from unknown and unreliable sources.
\n5. \u0007Increased vigilance by health care professionals and patients can help make public and individual
\nhealth safer. When prescribing, dispensing or administering medicines, health professionals need to
\nconsider and report counterfeit medicines as a reason for non-response or unexpected response in
\npharmacotherapy in the patients they care for.
\n6. \u0007International specialised agencies responsible for procuring and distributing medical products should
\nidentify substandard and counterfeit medical products and publish a list of these products, so that steps
\ncan be taken to remove these medical products from the market when discovered.
\n7. \u0007National governments are positioned to play a key role in eliminating counterfeit medical products
\nby the enforcement of pharmaceutical and penal legislation through efficient prosecution, by ensuring
\nadherence to Good Manufacturing Practices (GMP), Good Distribution Practices (GDP) and Good
\nPharmacy Practices (GPP) and by increasing national drug regulatory capacity and performance.
\nA.J.M. Hoek
\nGeneral Secretary & CEO, International Pharmaceutical Federation (FIP)
\nOtmar Kloiber
\nSecretary General, World Medical Association
\nDavid Benton
\nChief Executive Officer, International Council of Nurses
\nDavid C. Alexander
\nExecutive Director, FDI World Dental Federation
\nBrenda J. Myers
\nSecretary General,World Confederation for Physical Therapy (WCPT)
\nMarch 2010<\/p>\n"},"caption":{"rendered":"

WHPA_Joint_Statement_on_Counterfeiting … WHPAjointstatementoncounterfeitingofmedicalproducts Background All health care professionals have a common goal to protect the well-being of patients in all parts of the world from poor quality, substandard and counterfeit medical products. Pro-active steps must be taken in collaboration with Governments and other key stakeholders of the legitimate supply chain such as the pharmaceutical manufacturers […]<\/p>\n"},"alt_text":"","media_type":"file","mime_type":"application\/pdf","media_details":{},"post":926,"source_url":"https:\/\/www.wma.net\/wp-content\/uploads\/2016\/11\/WHPA_Joint_Statement_on_Counterfeiting.pdf","_links":{"self":[{"href":"https:\/\/www.wma.net\/es\/wp-json\/wp\/v2\/media\/5849"}],"collection":[{"href":"https:\/\/www.wma.net\/es\/wp-json\/wp\/v2\/media"}],"about":[{"href":"https:\/\/www.wma.net\/es\/wp-json\/wp\/v2\/types\/attachment"}],"author":[{"embeddable":true,"href":"https:\/\/www.wma.net\/es\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.wma.net\/es\/wp-json\/wp\/v2\/comments?post=5849"}]}}